Since 2003, we have been instrumental in the development of 24 new diagnostic tools.

Over 50 million FIND-supported products have been provided to 150 low- and middle-income countries since the start of 2015.

Our work has been transformative in the diagnosis of tuberculosis and malaria and helped bring sleeping sickness elimination within reach.

By 2020, we are seeking to achieve multiple diagnostic breakthroughs, from point-of-care tests that will help patients access appropriate treatment for diseases including TB and hepatitis C, to advances in digital tools to make diagnostic data useful in low-resource settings for clinical care and surveillance.


Diagnosis matters